Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients

Published:2008-03 Issue:5 Volume:177 Page:498-505
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Nobre Vandack,Harbarth Stephan,Graf Jean-Daniel,Rohner Peter,Pugin Jérôme

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference29 articles.

1. The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit

2. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study

3. Cost of Gram-negative resistance*

4. Healthcare Epidemiology: Does Antibiotic Selection Impact Patient Outcome?

5. Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults

Cited by 497 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits and Harms of Procalcitonin- or C-Reactive Protein-Guided Antimicrobial Discontinuation in Critically Ill Adults With Sepsis: A Systematic Review and Network Meta-Analysis;Critical Care Medicine;2024-07-01

2. Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use;World Journal of Emergency Surgery;2024-06-08

3. Intra-abdominal infections survival guide: a position statement by the Global Alliance For Infections In Surgery;World Journal of Emergency Surgery;2024-06-08

4. Evaluation of Serial Procalcitonin Levels for the Optimization of Antibiotic Use in Non-Critically Ill COVID-19 Patients;Pharmaceuticals;2024-05-12

5. Development and Validation of the First FDA Authorized Artificial Intelligence/Machine Learning Diagnostic Tool for the Prediction of Sepsis Risk;2024-05-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3